The emerging practice of inhaling 5meo dimethyltryptamine in Canada presents serious hazards and complicated juridical issues. Currently, 5MeO copyright remains a Controlled Number One substance within the legislation, causing its ownership and sale prohibited. While inhalation delivers the compound rapidly, it besides poses unique physical dangers